Lei Xiyao, Cao Zhuo, Wu Yibo, Lin Jie, Zhang Zhenhua, Jin Juebin, Ai Yao, Zhang Ji, Du Dexi, Tian Zhifeng, Xie Congying, Yin Weiwei, Jin Xiance
Department of Radiation Oncology, Lishui Municipal Central Hospital, Lishui, 323000, China.
Department of Radiotherapy Center, 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Insights Imaging. 2023 Oct 15;14(1):174. doi: 10.1186/s13244-023-01528-0.
Preoperative stratification is critical for the management of patients with esophageal cancer (EC). To investigate the feasibility and accuracy of PET-CT-based radiomics in preoperative prediction of clinical and pathological stages for patients with EC.
Histologically confirmed 100 EC patients with preoperative PET-CT images were enrolled retrospectively and randomly divided into training and validation cohorts at a ratio of 7:3. The maximum relevance minimum redundancy (mRMR) was applied to select optimal radiomics features from PET, CT, and fused PET-CT images, respectively. Logistic regression (LR) was applied to classify the T stage (T vs. T), lymph node metastasis (LNM) (LNM vs. LNM), and pathological state (pstage) (I-II vs. III-IV) with features from CT (CT_LR_Score), PET (PET_LR_Score), fused PET/CT (Fused_LR_Score), and combined CT and PET features (CT + PET_LR_Score), respectively.
Seven, 10, and 7 CT features; 7, 8, and 7 PET features; and 3, 6, and 3 fused PET/CT features were selected using mRMR for the prediction of T stage, LNM, and pstage, respectively. The area under curves (AUCs) for T stage, LNM, and pstage prediction in the validation cohorts were 0.846, 0.756, 0.665, and 0.815; 0.769, 0.760, 0.665, and 0.824; and 0.727, 0.785, 0.689, and 0.837 for models of CT_LR_Score, PET_ LR_Score, Fused_ LR_Score, and CT + PET_ LR_Score, respectively.
Accurate prediction ability was observed with combined PET and CT radiomics in the prediction of T stage, LNM, and pstage for EC patients.
PET/CT radiomics is feasible and promising to stratify stages for esophageal cancer preoperatively.
• PET-CT radiomics achieved the best performance for Node and pathological stage prediction. • CT radiomics achieved the best AUC for T stage prediction. • PET-CT radiomics is feasible and promising to stratify stages for EC preoperatively.
术前分层对于食管癌(EC)患者的管理至关重要。旨在研究基于PET-CT的放射组学在术前预测EC患者临床和病理分期方面的可行性和准确性。
回顾性纳入100例经组织学确诊且术前行PET-CT检查的EC患者,并按7:3的比例随机分为训练组和验证组。分别应用最大相关最小冗余法(mRMR)从PET、CT及融合后的PET-CT图像中选择最佳放射组学特征。应用逻辑回归(LR)分别根据CT特征(CT_LR_Score)、PET特征(PET_LR_Score)、融合后的PET/CT特征(Fused_LR_Score)以及联合CT和PET特征(CT + PET_LR_Score)对T分期(T1-2期 vs. T3-4期)、淋巴结转移(LNM)(有LNM vs. 无LNM)及病理状态(p分期)(I-II期 vs. III-IV期)进行分类。
分别使用mRMR选择了7个、10个和7个CT特征;7个、8个和7个PET特征;以及3个、6个和3个融合后的PET/CT特征用于预测T分期、LNM和p分期。验证组中,CT_LR_Score、PET_LR_Score、Fused_LR_Score和CT + PET_LR_Score模型预测T分期、LNM和p分期的曲线下面积(AUC)分别为0.846、0.756、0.665和0.815;0.769、0.760、0.665和0.824;以及0.727、0.785、0.689和0.837。
联合PET和CT放射组学在预测EC患者的T分期、LNM和p分期方面具有准确的预测能力。
PET/CT放射组学在术前对食管癌进行分期具有可行性和前景。
• PET-CT放射组学在预测淋巴结和病理分期方面表现最佳。• CT放射组学在预测T分期方面AUC最佳。• PET-CT放射组学在术前对EC进行分期具有可行性和前景。